Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PTPRC | P08575 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.32 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22550372 | 0.96 | CA12 (0.33) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL22892375 | 0.95 | ALDH1A1 (0.33) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL22550376 | 0.91 | MGLL (0.35) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL22550393 | 0.88 | — | — | |
| SCHEMBL29849984 | 0.79 | ESR1 (0.51) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL22215860 | 0.79 | ESR1 (0.51) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL22550192 | 0.77 | MAPT (0.47) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL29850026 | 0.77 | MAPT (0.47) | CA12CA1CA9MAPTMEN1 | |
| SCHEMBL21888678 | 0.76 | GAA (0.38) | CA12CA1CA9MAPTKDM4E | |
| SCHEMBL9321659 | 0.76 | MGLL (0.56) | CA12CA1CA9KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873356-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11873356-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-10981865-B2 | Substituted or unsubstituted allyl group-containing maleimide compound, production method therefor, and composition and cured product using said compound | DIC CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20210032383-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2021-02-04 | — | — | US | disclosed |
| US-20200325101-A1 | SUBSTITUTED OR UNSUBSTITUTED ALLYL GROUP-CONTAINING MALEIMIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION AND CURED PRODUCT USING SAID COMPOUND | DIC CORPORATION (JP) | 2020-10-15 | — | — | US | disclosed |
| US-20200109276-A1 | COMPOSITION, CURED PRODUCT AND LAMINATE | DIC CORPORATION (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981865-B2 | Substituted or unsubstituted allyl group-containing maleimide compound, production method therefor, and composition and cured product using said compound | BMI1, WEE1, WEE2 | CA12 3973/4885CA1 4034/4885CA9 3007/4885 |
| US-20200325101-A1 | SUBSTITUTED OR UNSUBSTITUTED ALLYL GROUP-CONTAINING MALEIMIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION AND CURED PRODUCT USING SAID COMPOUND | BMI1, WEE1, WEE2 | CA12 3973/4885CA1 4034/4885CA9 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.